Person 1
ImmuONE
April 8, 2025
Nulla consequat massa quis enim. Praesent venenatis metus at tortor pulvinar varius. Nunc egestas, augue at pellentesque laoreet, felis eros vehicula leo, at malesuada velit
CRACK IT Challenge 36: Winners Phase 2
Following successful completion of the Phase 1 challenge awarded to ImmuONE by NC3Rs, we were announced as the winners for the Phase 2 challenge in January 2022. Sponsored by Unilever and AstraZeneca, the project aims to establish and develop in vitro OECD test guideline assays; free from animal-derived products and demonstrate their equivalence and superiority to current strategies. Once optimised, these technologies will progress to commercially ready, human relevant, animal-free bioassays with the view of gaining regulatory acceptance.
Add a Comment
Related Posts
ImmuONE makes Santander semi-finals
ImmuONE
June 30, 2019
DateCategoryReading Time10 minutes ImmuONE entered the Santander Universities Entrepreneurship Awards representing the University of Hertfordshire. After successfully completing the first two rounds they are through
ImmuONE awarded Innovate UK funding
ImmuONE
October 31, 2019
ImmuONE won their bid in a competitive funding round from Innovate UK to commercialise their first product in the pipeline, ImmuLUNG™. The technology provides an